The UK government will shortly trigger Brexit under Article 50, opening up negotiations which are expected to see the country leave the European Union by March 2019.
The US regulator has given a Fast Track designation to a Shire pipeline drug for a life-threatening blood clotting disease, hereditary thrombotic thrombocytopenic purpura.